Cross-border rare disease advocacy: Preethi Krishnaraj interviews Harsha Rajasimha
- PMID: 38270284
- PMCID: PMC10846506
- DOI: 10.1242/dmm.050672
Cross-border rare disease advocacy: Preethi Krishnaraj interviews Harsha Rajasimha
Figures


References
-
- Khera, H. K., Venugopal, N., Karur, R. T., Mishra, R., Kartha, R. V. and Rajasimha, H. K. (2022). Building cross-border collaborations to increase diversity and accelerate rare disease drug development - meeting report from the inaugural IndoUSrare Annual Conference 2021. Ther. Adv. Rare Dis. 3. 10.1177/26330040221133124 - DOI - PMC - PubMed
-
- Nguengang Wakap, S., Lambert, D. M., Olry, A., Rodwell, C., Gueydan, C., Lanneau, V., Murphy, D., Le Cam, Y. and Rath, A. (2020). Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur. J. Hum. Genet. 28, 165-173. 10.1038/s41431-019-0508-0 - DOI - PMC - PubMed
-
- Rajasimha, H. K., Shirol, P. B., Ramamoorthy, P., Hegde, M., Barde, S., Chandru, V., Ravinandan, M. E., Ramachandran, R., Haldar, K., Lin, J. C.et al. (2014). Organization for Rare Diseases India (ORDI) – addressing the challenges and opportunities for the indian rare diseases’ community. Genetics Research 96, e009. 10.1017/S0016672314000111 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical